US Venture Partners X L.P., 10% Owner at eFFECTOR Therapeutics, Inc. (EFTR), sold 46,176 shares at $2.00 ($86K) on 2022-05-12, disclosed to the SEC on 2022-05-16.
Open-market sale of $86k EFTR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.00 | 336 | $672 | 0.8% |
| 2 | $2.00 | 10,464 | $21K | 24.5% |
| 3 | $1.84 | 701 | $1K | 1.5% |
| 4 | $1.84 | 21,906 | $40K | 47.1% |
| 5 | $1.75 | 395 | $691 | 0.8% |
| 6 | $1.75 | 12,374 |
| $22K |
| 25.3% |
| Total | $1.85 avg | 46,176 | $86K | 100% |
| Filing → |
| EFTR | SELL | 2021-12-06 | $46K | — | Filing → |
| EFTR | SELL | 2021-11-26 | $781K | — | Filing → |
| NARI | BUY | 2020-05-27 | $1.9M | — | Filing → |